Chronic glial NF-κB activation drives cytokine-mediated dopaminergic toxicity. IKKβ inhibition theoretically reduces neuroinflammation but faces severe safety liabilities (immunosuppression, malignancy risk) and complete absence of human validation, compounded by failed NF-κB-targeting trials in ALS/MS.
No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for IKKΒ yet. Search RCSB →
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for IKKβ (CHUK).
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.